D. E. Shaw Research is a leading New York–based computational biochemistry research laboratory, specializing in molecular simulation and drug discovery. The firm develops advanced technologies to model and understand the behavior of biologically and pharmaceutically important molecules at the atomic level. Leveraging cutting-edge biomolecular modeling software, machine learning techniques, and high-performance computing, DESRES drives both internal research projects and collaborative pharmaceutical programs. A hallmark of its innovation is Anton, a proprietary supercomputer designed to accelerate molecular dynamics simulations, enabling breakthroughs in protein folding, drug design, and computational chemistry.
ABOUT D. E. SHAW RESEARCH
D. E. Shaw Research is a private research firm specializing in computational biochemistry and drug discovery.
The firm employs an interdisciplinary approach, combining expertise in computer science, chemistry, biology, and engineering to drive innovations in molecular dynamics simulations and pharmaceutical research.
DESRES is active across the biotechnology, healthcare, and big data sectors, developing advanced biomolecular modeling methods, software, and machine learning techniques.
A cornerstone of the firm’s technological capabilities is ANTON®, a proprietary supercomputer engineered to perform molecular dynamics simulations over 100 times faster than the world’s fastest general-purpose supercomputers.
The team at D. E. Shaw Research includes computational chemists and biologists, computer scientists and applied mathematicians, as well as computer architects and engineers, all working together to push the boundaries of scientific research.
DESRES SERVICES
Drug Discovery
Designing novel drug candidates through advanced computational methods, followed by experimental validation to evaluate efficacy and safety.
Structural Biology
Investigating the atomic-level structures of proteins and other biomolecules to inform drug design and understand disease mechanisms.
Research Collaborations
Partnering with academic institutions, research centers, and pharmaceutical companies to advance scientific knowledge and develop new therapeutic strategies.
Educational Resources
Providing access to scientific publications and resources to support the broader research and academic community.